emig.org.uk Report : Visit Site

Technical data of the emig.org.uk

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host emig.org.uk. Currently, hosted in United Kingdom and its service provider is Dataflame Internet Services Ltd .

the related websites

emig.co.uk refrescogerber.co.uk mavtv.com solarkinguk.com wesleyjohnston.com data-wales.co.uk thegrocer.co.uk dirtbikebitz.com ancestor.abel.co.uk cisco.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

home about who we are members list what we do testimonials how we work special interest groups our mission & values our work our priorities eucope enhancing regulation the 2019 pprs better research for better outcomes the pharmaceutical industry & the nhs members loading... emig is a network of life sciences companies and organisations with an influential voice in government, working to advance patient access to medicines. read more about emig emig members supply 50% of the branded medicines prescribed to patients in the nhs and span life sciences companies of all sizes and in all segments –pharmaceuticals, biotechnology, generics, biosimilars and medical technology. read more about emig emig mission is to work closely with government, regulators, hta bodies, academia, medical research organisations and the nhs to advance patient access to the most effective and innovative medicines; to promote the uk as an attractive environment for research and investment; and to enhance our members’ ability to operate effectively. read more about emig emig network emig has over 270 members spanning the health research and medicines ecosystem: from research, clinical development and manufacturing, through to patient charities, research policy organisations and academic institutions. read more about emig why listen? we are the sole representative body for 90% of our members. read more about emig why join? we provide practical help, advice, information and networking opportunities for members, whose views we represent to government, regulators, hta bodies and other nhs decision makers across the four nations. become a member home2 admin 2017-11-11t17:49:17+00:00 member’s log-in emig priorities leadership in life sciences better research for better outcomes in the uk pprs leadership in life sciences government needs to act now and present its vision for the sector post brexit. this includes protecting the research ecosystem from uncertainty so that inward investment is not threatened, access to the eu regulatory framework, preserving the single market for medicines and to facilitate access to the people skills that are essential to the delivery of medicines to patients in the uk. the european medicines agency (ema) is currently responsible for marketing authorisations (ma) covering all 31 countries in europe (including eea countries). a ma submission for the uk alone will require the same level of company resource and will attract a lower priority in comparison. the uk could therefore be downgraded in the global launch sequence for new medicines. this would have negative consequences for patients, clinical research and the economy. the uk’s medical research charities play an increasingly important role to make the country an attractive place to invest. the members of the association of medical research charities (amrc) fund £1.6bn worth of research per year and increasingly in a more strategic way involving commercial collaborations. for example, myeloma uk has a number of such collaborations with more in the pipeline. the depth and breadth of world-class clinical science supported via the nihr in england is enormous. it has pioneered successful new models of industry/academia/nhs collaboration such as the translational research partnerships programme, and put in place several organisational measures to help industry navigate what is undoubtedly a complex environment. better research for better outcomes in the uk stakeholders need to collaborate on measures to drive alignment between research programmes that generate data for market authorisation with the requirements of uk health technology appraisals. a new uk value framework for better research should be developed. uk academics should be incentivised to design innovative clinical trials in partnership with industry to generate uk-facing regulatory standard data. new flexible approaches to pricing and patient access schemes should be designed. the time between regulatory approval, hta and adoption by the nhs should be shortened. pprs in order for the pprs to fully meet its stated goals the 2019 pprs should include:- a new medicines fund, sponsored by continued industry rebates, that would pay for, inter alia, all new medicines launched during the period of the scheme plus all medicines prioritised under nhs england commissioning prioritisation and would obviate the need for the nhs affordability criteria and the nice qaly threshold for highly specialised technologies (hst). the pprs ‘taper’ should be restored, with a higher exemption threshold of £10m and applied to companies up to £40m in annual turnover. {{options.title}} {{single.title}} {{single.start | moment( options.label_dateformat ? options.label_dateformat : 'dddd, mmmm d' ) }} {{options.label_wcs_type}} {{options.label_wcs_room}} {{options.label_wcs_instructor}} {{single.excerpt}} {{remaining_years | leadingzero}} {{remaining_months | leadingzero}} {{remaining_days | leadingzero}} {{remaining_hours | leadingzero}} {{remaining_minutes | leadingzero}} {{remaining_seconds | leadingzero}} {{options.label_info}} to become an emig member. click to find out how save home about who we are members list what we do testimonials how we work special interest groups our mission & values our work our priorities eucope enhancing regulation the 2019 pprs better research for better outcomes the pharmaceutical industry & the nhs members © copyright 2017 - ethical medicines industry group | ethical medicines industry group (emig), 118 pall mall, london sw1a 5ed | terms & conditions | privacy policy | cookie policy this website uses cookies to improve your experience. if you continue using this website, you agree with our privacy policy and our cookie policy. more information accept

URL analysis for emig.org.uk

http://emig.org.uk/membership-join/
http://emig.org.uk/emig-cookie-policy/
http://emig.org.uk/author/admin/
http://emig.org.uk/about-emig-2/#howwework
http://emig.org.uk/about-emig-2/#sigs
http://emig.org.uk/about-emig-2/#testimonials
http://emig.org.uk/#tab-9ccee77019c3b7f83a3
http://emig.org.uk/our-work/#regulation
http://emig.org.uk/about-emig-2/#whatwedo
http://emig.org.uk/emig-members-page/
http://emig.org.uk/our-work/#pprs
http://emig.org.uk/emig-terms-and-conditions/
http://emig.org.uk/#tab-8e7bb4f4c302b45a966
http://emig.org.uk/our-work/#priorities
http://emig.org.uk/about-emig-2/#whoweare

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain name:
emig.org.uk

Registrant:
Alex Winslow-Fowler

Trading as:
Eclipse Net Solutions

Registrant type:
UK Sole Trader

Registrant's address:
Hinckley
Hinckley
LE10 1EY
United Kingdom

Data validation:
Nominet was not able to match the registrant's name and/or address against a 3rd party source on 20-Sep-2013

Registrar:
123-Reg Limited t/a 123-reg [Tag = 123-REG]
URL: http://www.123-reg.co.uk

Relevant dates:
Registered on: 24-Jan-2007
Expiry date: 24-Jan-2019
Last updated: 17-Jan-2017

Registration status:
Registered until expiry date.

Name servers:
ns.123-reg.co.uk 212.67.202.2
ns2.123-reg.co.uk 62.138.132.21

WHOIS lookup made at 19:28:15 11-Jul-2017

--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:

Copyright Nominet UK 1996 - 2017.

You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REFERRER http://www.nominet.org.uk

  REGISTRAR Nominet UK

SERVERS

  SERVER uk.whois-servers.net

  ARGS emig.org.uk

  PORT 43

  TYPE domain

OWNER

  ORGANIZATION Alex Winslow-Fowler

TYPE
UK Sole Trader

ADDRESS
Hinckley
Hinckley
LE10 1EY
United Kingdom
Data validation:
Nominet was not able to match the registrant's name and/or address against a 3rd party source on 20-Sep-2013

DOMAIN

  SPONSOR 123-Reg Limited t/a 123-reg [Tag = 123-REG]

  CREATED 2007-01-24

  CHANGED 2017-01-17

STATUS
Registered until expiry date.

NSERVER

  NS.123-REG.CO.UK 212.67.202.2

  NS2.123-REG.CO.UK 62.138.132.21

  NAME emig.org.uk

DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .